We are live on ! Find out more
OMC

OUP Management Company Portfolio holdings

AUM $44.5M
1-Year Est. Return 55.11%
This Fund
S&P 500
This Quarter Est. Return
-5.59%
1 Year Est. Return
+55.11%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$50.1M
AUM Growth
-$11.1M
Cap. Flow
-$3.69M
Cap. Flow %
-7.36%
Top 10 Hldgs %
96.74%
Holding
14
New
–
Increased
–
Reduced
1
Closed
–

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
IONQ icon
IonQ
IONQ
+$3.69M

Sector Composition

Rank Sector Weight
1 Healthcare 95.22%
2 Technology 4.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JBIO
1
Jade Biosciences
JBIO
$1.34B
$12.2M 24.3%
17,250
– –
CNTA
2
DELISTED
Centessa Pharmaceuticals
CNTA
$11.3M 22.57%
2,937,615
– –
DICE
3
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$7.69M 15.34%
268,346
– –
PMVP icon
4
PMV Pharmaceuticals
PMVP
$61.3M
$4.72M 9.42%
989,232
– –
CYT
5
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$4.48M 8.93%
2,459,572
– –
IONQ icon
6
IonQ
IONQ
$15.1B
$2.4M 4.78%
389,668
-787,929
-67% -$3.69M
VOR icon
7
Vor Biopharma
VOR
$1.25B
$2.02M 4.02%
18,736
– –
PRME icon
8
Prime Medicine
PRME
$527M
$1.49M 2.98%
121,255
– –
RNAC icon
9
Cartesian Therapeutics
RNAC
$253M
$1.2M 2.39%
28,751
– –
LENZ
10
LENZ Therapeutics
LENZ
$162M
$995K 1.99%
58,044
– –
DTIL icon
11
Precision BioSciences
DTIL
$188M
$847K 1.69%
37,464
– –
EFTR
12
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
$362K 0.72%
41,028
– –
SPRO icon
13
Spero Therapeutics
SPRO
$72.4M
$361K 0.72%
249,070
– –
QTTB icon
14
Q32 Bio
QTTB
$482M
$65.9K 0.13%
3,556
– –

Similar funds

JMF
Johnson Midwest Financial Glidden, Iowa $44.7M AUM 21.66% 1-Year Est. Return
AMC
Avenir Management Company New York $43.8M AUM 101.91% 1-Year Est. Return
MCAV
Meritech Capital Associates VI Palo Alto, California $45.3M AUM 4.6% 1-Year Est. Return
SIP
Scott Investment Partners Henley-On-Thames, United Kingdom $43.5M AUM 17.97% 1-Year Est. Return
KXA
KPCB XIV Associates Menlo Park, California $42.8M AUM 16.52% 1-Year Est. Return
WRCAI
West Rim Capital Associates II Lehi, Utah $46.8M AUM 11.72% 1-Year Est. Return
MAM
Must Asset Management Seoul, South Korea $40.9M AUM 22.53% 1-Year Est. Return
GIA
G2VP I Associates Portola Valley, California $48.2M AUM 37.59% 1-Year Est. Return

OUP Management Company's Q1 2023 Portfolio in Review

As of Q1 2023, OUP Management Company held 14 positions worth $50.1M, down 18% from $61.3M the previous quarter. Its ten largest holdings account for 97% of the portfolio.

OUP Management Company withdrew a net $3.69M in Q1 2023, reducing 1 holding. Its largest reduction was IonQ, cutting an estimated $3.69M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 93% a quarter earlier, followed by Technology.

  • OUP Management Company's biggest Q1 2023 reduction was IonQ, cutting an estimated $3.69M.
  • OUP Management Company's ten largest holdings make up 97% of its $50.1M portfolio in Q1 2023.
  • OUP Management Company opened 0 new positions and closed 0 in Q1 2023.
  • OUP Management Company's portfolio value fell 18% quarter-over-quarter to $50.1M.

Based on OUP Management Company's 13F filing for Q1 2023, filed 24 Apr 2023.